We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Its Stance Going Into GDUF Negotiations With Industry
FDA Clarifies Its Stance Going Into GDUF Negotiations With Industry
February 24, 2011
In light of rumors to the contrary, the FDA said recently that it has not held any negotiations with industry yet regarding generic-drug user fees (GDUF) and it “has not reached any conclusions regarding how a generic-drug user fee program should be structured.”